nodes	percent_of_prediction	percent_of_DWPC	metapath
Carteolol—CYP2D6—Alzheimer's disease	0.466	1	CbGaD
Carteolol—CYP2D6—Rivastigmine—Alzheimer's disease	0.168	0.432	CbGbCtD
Carteolol—CYP2D6—Donepezil—Alzheimer's disease	0.134	0.345	CbGbCtD
Carteolol—CYP2D6—Galantamine—Alzheimer's disease	0.0864	0.223	CbGbCtD
Carteolol—Cerebral ischaemia—Donepezil—Alzheimer's disease	0.00501	0.0388	CcSEcCtD
Carteolol—Block heart—Donepezil—Alzheimer's disease	0.00426	0.033	CcSEcCtD
Carteolol—Block heart—Memantine—Alzheimer's disease	0.00387	0.03	CcSEcCtD
Carteolol—Atrioventricular block—Galantamine—Alzheimer's disease	0.00322	0.0249	CcSEcCtD
Carteolol—Eye irritation—Donepezil—Alzheimer's disease	0.00283	0.022	CcSEcCtD
Carteolol—Atrioventricular block—Donepezil—Alzheimer's disease	0.00249	0.0193	CcSEcCtD
Carteolol—Cerebrovascular accident—Galantamine—Alzheimer's disease	0.00231	0.0179	CcSEcCtD
Carteolol—Atrioventricular block—Memantine—Alzheimer's disease	0.00226	0.0175	CcSEcCtD
Carteolol—Respiratory failure—Memantine—Alzheimer's disease	0.00224	0.0173	CcSEcCtD
Carteolol—Atrioventricular block—Rivastigmine—Alzheimer's disease	0.00222	0.0172	CcSEcCtD
Carteolol—Respiratory failure—Rivastigmine—Alzheimer's disease	0.00219	0.017	CcSEcCtD
Carteolol—Diabetes mellitus—Donepezil—Alzheimer's disease	0.00202	0.0156	CcSEcCtD
Carteolol—Cardiac failure congestive—Donepezil—Alzheimer's disease	0.00194	0.015	CcSEcCtD
Carteolol—Diabetes mellitus—Memantine—Alzheimer's disease	0.00183	0.0142	CcSEcCtD
Carteolol—Hypoglycaemia—Donepezil—Alzheimer's disease	0.0018	0.0139	CcSEcCtD
Carteolol—Diabetes mellitus—Rivastigmine—Alzheimer's disease	0.00179	0.0139	CcSEcCtD
Carteolol—Cerebrovascular accident—Donepezil—Alzheimer's disease	0.00179	0.0139	CcSEcCtD
Carteolol—Cardiac failure congestive—Memantine—Alzheimer's disease	0.00176	0.0136	CcSEcCtD
Carteolol—Depression—Galantamine—Alzheimer's disease	0.00174	0.0135	CcSEcCtD
Carteolol—Hypoglycaemia—Memantine—Alzheimer's disease	0.00163	0.0127	CcSEcCtD
Carteolol—Cerebrovascular accident—Memantine—Alzheimer's disease	0.00163	0.0126	CcSEcCtD
Carteolol—Hypoglycaemia—Rivastigmine—Alzheimer's disease	0.0016	0.0124	CcSEcCtD
Carteolol—Bradycardia—Galantamine—Alzheimer's disease	0.0016	0.0124	CcSEcCtD
Carteolol—Diplopia—Memantine—Alzheimer's disease	0.00159	0.0124	CcSEcCtD
Carteolol—Cerebrovascular accident—Rivastigmine—Alzheimer's disease	0.00159	0.0123	CcSEcCtD
Carteolol—Diplopia—Rivastigmine—Alzheimer's disease	0.00156	0.0121	CcSEcCtD
Carteolol—Visual impairment—Galantamine—Alzheimer's disease	0.00151	0.0117	CcSEcCtD
Carteolol—Arrhythmia—Galantamine—Alzheimer's disease	0.0014	0.0109	CcSEcCtD
Carteolol—Bronchospasm—Memantine—Alzheimer's disease	0.00136	0.0105	CcSEcCtD
Carteolol—Depression—Donepezil—Alzheimer's disease	0.00135	0.0105	CcSEcCtD
Carteolol—Dysgeusia—Galantamine—Alzheimer's disease	0.00134	0.0104	CcSEcCtD
Carteolol—Bronchospasm—Rivastigmine—Alzheimer's disease	0.00133	0.0103	CcSEcCtD
Carteolol—Conjunctivitis—Donepezil—Alzheimer's disease	0.00132	0.0102	CcSEcCtD
Carteolol—Vision blurred—Galantamine—Alzheimer's disease	0.00129	0.00997	CcSEcCtD
Carteolol—Bradycardia—Donepezil—Alzheimer's disease	0.00124	0.00958	CcSEcCtD
Carteolol—Depression—Memantine—Alzheimer's disease	0.00123	0.0095	CcSEcCtD
Carteolol—Syncope—Galantamine—Alzheimer's disease	0.00122	0.00948	CcSEcCtD
Carteolol—Palpitations—Galantamine—Alzheimer's disease	0.00121	0.00935	CcSEcCtD
Carteolol—Loss of consciousness—Galantamine—Alzheimer's disease	0.0012	0.00929	CcSEcCtD
Carteolol—Depression—Rivastigmine—Alzheimer's disease	0.0012	0.00929	CcSEcCtD
Carteolol—Conjunctivitis—Memantine—Alzheimer's disease	0.00119	0.00926	CcSEcCtD
Carteolol—Visual impairment—Donepezil—Alzheimer's disease	0.00117	0.00907	CcSEcCtD
Carteolol—Conjunctivitis—Rivastigmine—Alzheimer's disease	0.00117	0.00906	CcSEcCtD
Carteolol—Sinusitis—Memantine—Alzheimer's disease	0.00115	0.00893	CcSEcCtD
Carteolol—Sinusitis—Rivastigmine—Alzheimer's disease	0.00113	0.00874	CcSEcCtD
Carteolol—Bradycardia—Memantine—Alzheimer's disease	0.00112	0.0087	CcSEcCtD
Carteolol—Bradycardia—Rivastigmine—Alzheimer's disease	0.0011	0.00851	CcSEcCtD
Carteolol—Shock—Galantamine—Alzheimer's disease	0.0011	0.00849	CcSEcCtD
Carteolol—Arrhythmia—Donepezil—Alzheimer's disease	0.00109	0.00841	CcSEcCtD
Carteolol—Visual impairment—Memantine—Alzheimer's disease	0.00106	0.00824	CcSEcCtD
Carteolol—Hypotension—Galantamine—Alzheimer's disease	0.00104	0.00807	CcSEcCtD
Carteolol—Visual impairment—Rivastigmine—Alzheimer's disease	0.00104	0.00806	CcSEcCtD
Carteolol—Dysgeusia—Donepezil—Alzheimer's disease	0.00104	0.00803	CcSEcCtD
Carteolol—Insomnia—Galantamine—Alzheimer's disease	0.00101	0.00781	CcSEcCtD
Carteolol—Vision blurred—Donepezil—Alzheimer's disease	0.000997	0.00772	CcSEcCtD
Carteolol—Arrhythmia—Memantine—Alzheimer's disease	0.000986	0.00764	CcSEcCtD
Carteolol—Arrhythmia—Rivastigmine—Alzheimer's disease	0.000964	0.00747	CcSEcCtD
Carteolol—Syncope—Donepezil—Alzheimer's disease	0.000949	0.00735	CcSEcCtD
Carteolol—Dysgeusia—Memantine—Alzheimer's disease	0.00094	0.00729	CcSEcCtD
Carteolol—Loss of consciousness—Donepezil—Alzheimer's disease	0.00093	0.0072	CcSEcCtD
Carteolol—Dysgeusia—Rivastigmine—Alzheimer's disease	0.00092	0.00713	CcSEcCtD
Carteolol—Vision blurred—Memantine—Alzheimer's disease	0.000905	0.00701	CcSEcCtD
Carteolol—Vision blurred—Rivastigmine—Alzheimer's disease	0.000885	0.00686	CcSEcCtD
Carteolol—Oedema—Donepezil—Alzheimer's disease	0.000863	0.00669	CcSEcCtD
Carteolol—Syncope—Memantine—Alzheimer's disease	0.000861	0.00667	CcSEcCtD
Carteolol—Shock—Donepezil—Alzheimer's disease	0.000849	0.00658	CcSEcCtD
Carteolol—Palpitations—Memantine—Alzheimer's disease	0.000849	0.00658	CcSEcCtD
Carteolol—Loss of consciousness—Memantine—Alzheimer's disease	0.000844	0.00654	CcSEcCtD
Carteolol—Syncope—Rivastigmine—Alzheimer's disease	0.000843	0.00653	CcSEcCtD
Carteolol—Palpitations—Rivastigmine—Alzheimer's disease	0.00083	0.00643	CcSEcCtD
Carteolol—Loss of consciousness—Rivastigmine—Alzheimer's disease	0.000826	0.0064	CcSEcCtD
Carteolol—Hypersensitivity—Galantamine—Alzheimer's disease	0.000821	0.00636	CcSEcCtD
Carteolol—Hypotension—Donepezil—Alzheimer's disease	0.000807	0.00625	CcSEcCtD
Carteolol—Asthenia—Galantamine—Alzheimer's disease	0.000799	0.00619	CcSEcCtD
Carteolol—Oedema—Memantine—Alzheimer's disease	0.000784	0.00607	CcSEcCtD
Carteolol—Insomnia—Donepezil—Alzheimer's disease	0.000781	0.00605	CcSEcCtD
Carteolol—Shock—Memantine—Alzheimer's disease	0.000771	0.00598	CcSEcCtD
Carteolol—Dyspnoea—Donepezil—Alzheimer's disease	0.00077	0.00596	CcSEcCtD
Carteolol—Oedema—Rivastigmine—Alzheimer's disease	0.000767	0.00594	CcSEcCtD
Carteolol—Shock—Rivastigmine—Alzheimer's disease	0.000754	0.00585	CcSEcCtD
Carteolol—Dizziness—Galantamine—Alzheimer's disease	0.000737	0.00571	CcSEcCtD
Carteolol—Hypotension—Memantine—Alzheimer's disease	0.000732	0.00568	CcSEcCtD
Carteolol—Hypotension—Rivastigmine—Alzheimer's disease	0.000716	0.00555	CcSEcCtD
Carteolol—Insomnia—Memantine—Alzheimer's disease	0.000709	0.00549	CcSEcCtD
Carteolol—Dyspnoea—Memantine—Alzheimer's disease	0.000699	0.00541	CcSEcCtD
Carteolol—Headache—Galantamine—Alzheimer's disease	0.000698	0.00541	CcSEcCtD
Carteolol—Insomnia—Rivastigmine—Alzheimer's disease	0.000694	0.00537	CcSEcCtD
Carteolol—Dyspnoea—Rivastigmine—Alzheimer's disease	0.000684	0.0053	CcSEcCtD
Carteolol—Nausea—Galantamine—Alzheimer's disease	0.000662	0.00513	CcSEcCtD
Carteolol—Hypersensitivity—Donepezil—Alzheimer's disease	0.000636	0.00493	CcSEcCtD
Carteolol—Asthenia—Donepezil—Alzheimer's disease	0.000619	0.0048	CcSEcCtD
Carteolol—Hypersensitivity—Memantine—Alzheimer's disease	0.000577	0.00447	CcSEcCtD
Carteolol—Dizziness—Donepezil—Alzheimer's disease	0.000571	0.00442	CcSEcCtD
Carteolol—Hypersensitivity—Rivastigmine—Alzheimer's disease	0.000565	0.00438	CcSEcCtD
Carteolol—Asthenia—Memantine—Alzheimer's disease	0.000562	0.00436	CcSEcCtD
Carteolol—Asthenia—Rivastigmine—Alzheimer's disease	0.00055	0.00426	CcSEcCtD
Carteolol—Headache—Donepezil—Alzheimer's disease	0.000541	0.00419	CcSEcCtD
Carteolol—Dizziness—Memantine—Alzheimer's disease	0.000518	0.00402	CcSEcCtD
Carteolol—Nausea—Donepezil—Alzheimer's disease	0.000513	0.00397	CcSEcCtD
Carteolol—Dizziness—Rivastigmine—Alzheimer's disease	0.000507	0.00393	CcSEcCtD
Carteolol—Headache—Memantine—Alzheimer's disease	0.000491	0.0038	CcSEcCtD
Carteolol—Headache—Rivastigmine—Alzheimer's disease	0.00048	0.00372	CcSEcCtD
Carteolol—Nausea—Memantine—Alzheimer's disease	0.000466	0.00361	CcSEcCtD
Carteolol—Nausea—Rivastigmine—Alzheimer's disease	0.000455	0.00353	CcSEcCtD
Carteolol—ADRB2—GPCR downstream signaling—PYY—Alzheimer's disease	4.81e-05	0.00282	CbGpPWpGaD
Carteolol—ADRB1—GPCR ligand binding—NPY—Alzheimer's disease	4.74e-05	0.00278	CbGpPWpGaD
Carteolol—ADRB1—GPCR ligand binding—IAPP—Alzheimer's disease	4.71e-05	0.00276	CbGpPWpGaD
Carteolol—ADRB2—GPCR ligand binding—NPY—Alzheimer's disease	4.63e-05	0.00272	CbGpPWpGaD
Carteolol—ADRB2—GPCR ligand binding—IAPP—Alzheimer's disease	4.61e-05	0.0027	CbGpPWpGaD
Carteolol—ADRB1—GPCR ligand binding—CRH—Alzheimer's disease	4.57e-05	0.00268	CbGpPWpGaD
Carteolol—CYP2D6—Biological oxidations—PTGS1—Alzheimer's disease	4.5e-05	0.00264	CbGpPWpGaD
Carteolol—ADRB2—GPCR ligand binding—CRH—Alzheimer's disease	4.47e-05	0.00262	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—PYY—Alzheimer's disease	4.47e-05	0.00262	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—PYY—Alzheimer's disease	4.37e-05	0.00256	CbGpPWpGaD
Carteolol—ADRB1—GPCR ligand binding—NPS—Alzheimer's disease	4.33e-05	0.00254	CbGpPWpGaD
Carteolol—ADRB2—GPCR ligand binding—NPS—Alzheimer's disease	4.24e-05	0.00248	CbGpPWpGaD
Carteolol—ADRB1—GPCR ligand binding—SST—Alzheimer's disease	4.13e-05	0.00242	CbGpPWpGaD
Carteolol—ADRB1—GPCR downstream signaling—HTR6—Alzheimer's disease	4.1e-05	0.00241	CbGpPWpGaD
Carteolol—ADRB1—GPCRs, Class A Rhodopsin-like—CCR5—Alzheimer's disease	4.08e-05	0.00239	CbGpPWpGaD
Carteolol—ADRB2—GPCR ligand binding—SST—Alzheimer's disease	4.04e-05	0.00237	CbGpPWpGaD
Carteolol—ADRB1—GPCR ligand binding—APP—Alzheimer's disease	4.03e-05	0.00236	CbGpPWpGaD
Carteolol—ADRB2—GPCR downstream signaling—HTR6—Alzheimer's disease	4.01e-05	0.00235	CbGpPWpGaD
Carteolol—ADRB1—GPCRs, Class A Rhodopsin-like—HTR2A—Alzheimer's disease	4e-05	0.00234	CbGpPWpGaD
Carteolol—ADRB2—GPCRs, Class A Rhodopsin-like—CCR5—Alzheimer's disease	3.99e-05	0.00234	CbGpPWpGaD
Carteolol—ADRB2—GPCR ligand binding—APP—Alzheimer's disease	3.94e-05	0.00231	CbGpPWpGaD
Carteolol—ADRB2—GPCRs, Class A Rhodopsin-like—HTR2A—Alzheimer's disease	3.91e-05	0.00229	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—CDK5—Alzheimer's disease	3.87e-05	0.00227	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—CDK5—Alzheimer's disease	3.79e-05	0.00222	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—HTR6—Alzheimer's disease	3.73e-05	0.00218	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—HTR6—Alzheimer's disease	3.65e-05	0.00214	CbGpPWpGaD
Carteolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CCR5—Alzheimer's disease	3.5e-05	0.00205	CbGpPWpGaD
Carteolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR2A—Alzheimer's disease	3.42e-05	0.00201	CbGpPWpGaD
Carteolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CCR5—Alzheimer's disease	3.42e-05	0.00201	CbGpPWpGaD
Carteolol—ADRB1—GPCR downstream signaling—GAL—Alzheimer's disease	3.41e-05	0.002	CbGpPWpGaD
Carteolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR2A—Alzheimer's disease	3.35e-05	0.00196	CbGpPWpGaD
Carteolol—ADRB2—GPCR downstream signaling—GAL—Alzheimer's disease	3.33e-05	0.00195	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—GAL—Alzheimer's disease	3.1e-05	0.00181	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—GAL—Alzheimer's disease	3.03e-05	0.00177	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—TTR—Alzheimer's disease	3.02e-05	0.00177	CbGpPWpGaD
Carteolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—F2—Alzheimer's disease	3e-05	0.00176	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—TTR—Alzheimer's disease	2.95e-05	0.00173	CbGpPWpGaD
Carteolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—F2—Alzheimer's disease	2.94e-05	0.00172	CbGpPWpGaD
Carteolol—ADRB1—GPCR downstream signaling—NPY—Alzheimer's disease	2.68e-05	0.00157	CbGpPWpGaD
Carteolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CCL2—Alzheimer's disease	2.67e-05	0.00157	CbGpPWpGaD
Carteolol—ADRB1—GPCR ligand binding—CCR5—Alzheimer's disease	2.66e-05	0.00156	CbGpPWpGaD
Carteolol—ADRB1—GPCR downstream signaling—IAPP—Alzheimer's disease	2.66e-05	0.00156	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—PYY—Alzheimer's disease	2.64e-05	0.00155	CbGpPWpGaD
Carteolol—ADRB2—GPCR downstream signaling—NPY—Alzheimer's disease	2.62e-05	0.00153	CbGpPWpGaD
Carteolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CCL2—Alzheimer's disease	2.62e-05	0.00153	CbGpPWpGaD
Carteolol—ADRB1—GPCR ligand binding—HTR2A—Alzheimer's disease	2.61e-05	0.00153	CbGpPWpGaD
Carteolol—ADRB2—GPCR ligand binding—CCR5—Alzheimer's disease	2.61e-05	0.00153	CbGpPWpGaD
Carteolol—ADRB2—GPCR downstream signaling—IAPP—Alzheimer's disease	2.6e-05	0.00153	CbGpPWpGaD
Carteolol—ADRB1—GPCR downstream signaling—CRH—Alzheimer's disease	2.58e-05	0.00151	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—PYY—Alzheimer's disease	2.58e-05	0.00151	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—DHCR24—Alzheimer's disease	2.55e-05	0.00149	CbGpPWpGaD
Carteolol—ADRB2—GPCR ligand binding—HTR2A—Alzheimer's disease	2.55e-05	0.00149	CbGpPWpGaD
Carteolol—ADRB2—GPCR downstream signaling—CRH—Alzheimer's disease	2.53e-05	0.00148	CbGpPWpGaD
Carteolol—ADRB1—GPCR downstream signaling—NPS—Alzheimer's disease	2.45e-05	0.00144	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—NPY—Alzheimer's disease	2.43e-05	0.00142	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—IAPP—Alzheimer's disease	2.42e-05	0.00142	CbGpPWpGaD
Carteolol—ADRB2—GPCR downstream signaling—NPS—Alzheimer's disease	2.4e-05	0.0014	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—NPY—Alzheimer's disease	2.38e-05	0.00139	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—IAPP—Alzheimer's disease	2.36e-05	0.00139	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—CRH—Alzheimer's disease	2.35e-05	0.00137	CbGpPWpGaD
Carteolol—ADRB1—GPCR downstream signaling—GAB2—Alzheimer's disease	2.34e-05	0.00137	CbGpPWpGaD
Carteolol—ADRB1—GPCR downstream signaling—SST—Alzheimer's disease	2.34e-05	0.00137	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—CRH—Alzheimer's disease	2.29e-05	0.00134	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—CDK5—Alzheimer's disease	2.29e-05	0.00134	CbGpPWpGaD
Carteolol—ADRB1—GPCR ligand binding—F2—Alzheimer's disease	2.29e-05	0.00134	CbGpPWpGaD
Carteolol—ADRB2—GPCR downstream signaling—GAB2—Alzheimer's disease	2.29e-05	0.00134	CbGpPWpGaD
Carteolol—ADRB2—GPCR downstream signaling—SST—Alzheimer's disease	2.29e-05	0.00134	CbGpPWpGaD
Carteolol—ADRB1—GPCR downstream signaling—APP—Alzheimer's disease	2.28e-05	0.00133	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—CDK5—Alzheimer's disease	2.24e-05	0.00131	CbGpPWpGaD
Carteolol—ADRB2—GPCR ligand binding—F2—Alzheimer's disease	2.24e-05	0.00131	CbGpPWpGaD
Carteolol—ADRB2—GPCR downstream signaling—APP—Alzheimer's disease	2.23e-05	0.00131	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—NPS—Alzheimer's disease	2.22e-05	0.0013	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—PPP3CA—Alzheimer's disease	2.21e-05	0.0013	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—HTR6—Alzheimer's disease	2.2e-05	0.00129	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—NPS—Alzheimer's disease	2.18e-05	0.00127	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—CA4—Alzheimer's disease	2.17e-05	0.00127	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—PPP3CA—Alzheimer's disease	2.16e-05	0.00127	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—HTR6—Alzheimer's disease	2.15e-05	0.00126	CbGpPWpGaD
Carteolol—ADRB1—GPCR downstream signaling—PLCB1—Alzheimer's disease	2.15e-05	0.00126	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—SST—Alzheimer's disease	2.12e-05	0.00124	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—GAB2—Alzheimer's disease	2.12e-05	0.00124	CbGpPWpGaD
Carteolol—ADRB2—GPCR downstream signaling—PLCB1—Alzheimer's disease	2.1e-05	0.00123	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—GAB2—Alzheimer's disease	2.08e-05	0.00122	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—SST—Alzheimer's disease	2.08e-05	0.00122	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—APP—Alzheimer's disease	2.07e-05	0.00121	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—GAPDHS—Alzheimer's disease	2.04e-05	0.0012	CbGpPWpGaD
Carteolol—ADRB1—GPCR ligand binding—CCL2—Alzheimer's disease	2.04e-05	0.00119	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—APP—Alzheimer's disease	2.02e-05	0.00119	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—PSENEN—Alzheimer's disease	2e-05	0.00117	CbGpPWpGaD
Carteolol—ADRB2—GPCR ligand binding—CCL2—Alzheimer's disease	1.99e-05	0.00117	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—APH1A—Alzheimer's disease	1.97e-05	0.00116	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—PSENEN—Alzheimer's disease	1.96e-05	0.00115	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—PLCB1—Alzheimer's disease	1.95e-05	0.00114	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—ATP5A1—Alzheimer's disease	1.93e-05	0.00113	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—APH1A—Alzheimer's disease	1.93e-05	0.00113	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—NCSTN—Alzheimer's disease	1.92e-05	0.00112	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—PLCB1—Alzheimer's disease	1.91e-05	0.00112	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—NCSTN—Alzheimer's disease	1.88e-05	0.0011	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—LRP1—Alzheimer's disease	1.87e-05	0.0011	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—PLD3—Alzheimer's disease	1.84e-05	0.00108	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—LRP1—Alzheimer's disease	1.83e-05	0.00107	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—GFAP—Alzheimer's disease	1.83e-05	0.00107	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—GAL—Alzheimer's disease	1.83e-05	0.00107	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—GFAP—Alzheimer's disease	1.79e-05	0.00105	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—GAL—Alzheimer's disease	1.79e-05	0.00105	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—HSD17B10—Alzheimer's disease	1.77e-05	0.00104	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—CYP46A1—Alzheimer's disease	1.7e-05	0.000997	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—ND1—Alzheimer's disease	1.64e-05	0.000963	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—A2M—Alzheimer's disease	1.61e-05	0.000944	CbGpPWpGaD
Carteolol—ADRB1—GPCR downstream signaling—PRKCG—Alzheimer's disease	1.59e-05	0.000931	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—A2M—Alzheimer's disease	1.58e-05	0.000924	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—PSEN2—Alzheimer's disease	1.56e-05	0.000915	CbGpPWpGaD
Carteolol—ADRB2—GPCR downstream signaling—PRKCG—Alzheimer's disease	1.55e-05	0.000911	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—PSEN2—Alzheimer's disease	1.53e-05	0.000895	CbGpPWpGaD
Carteolol—ADRB1—GPCR downstream signaling—CCR5—Alzheimer's disease	1.51e-05	0.000882	CbGpPWpGaD
Carteolol—ADRB1—GPCR downstream signaling—HTR2A—Alzheimer's disease	1.47e-05	0.000863	CbGpPWpGaD
Carteolol—ADRB2—GPCR downstream signaling—CCR5—Alzheimer's disease	1.47e-05	0.000863	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—PRKCG—Alzheimer's disease	1.44e-05	0.000845	CbGpPWpGaD
Carteolol—ADRB2—GPCR downstream signaling—HTR2A—Alzheimer's disease	1.44e-05	0.000844	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—NPY—Alzheimer's disease	1.44e-05	0.000842	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—IAPP—Alzheimer's disease	1.43e-05	0.000836	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—PRKCG—Alzheimer's disease	1.41e-05	0.000827	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—NPY—Alzheimer's disease	1.4e-05	0.000823	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—IAPP—Alzheimer's disease	1.4e-05	0.000818	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—CRH—Alzheimer's disease	1.39e-05	0.000812	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—CCR5—Alzheimer's disease	1.37e-05	0.000801	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—CRH—Alzheimer's disease	1.36e-05	0.000794	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—HTR2A—Alzheimer's disease	1.34e-05	0.000784	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—CCR5—Alzheimer's disease	1.34e-05	0.000784	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—NPS—Alzheimer's disease	1.31e-05	0.00077	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—HTR2A—Alzheimer's disease	1.31e-05	0.000767	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—PPP3CA—Alzheimer's disease	1.31e-05	0.000766	CbGpPWpGaD
Carteolol—ADRB1—GPCR downstream signaling—F2—Alzheimer's disease	1.29e-05	0.000757	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—PTK2B—Alzheimer's disease	1.29e-05	0.000755	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—NPS—Alzheimer's disease	1.29e-05	0.000753	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—PPP3CA—Alzheimer's disease	1.28e-05	0.000749	CbGpPWpGaD
Carteolol—ADRB2—GPCR downstream signaling—F2—Alzheimer's disease	1.26e-05	0.00074	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—PTK2B—Alzheimer's disease	1.26e-05	0.000738	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—SST—Alzheimer's disease	1.25e-05	0.000734	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—GAB2—Alzheimer's disease	1.25e-05	0.000734	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—NTRK2—Alzheimer's disease	1.25e-05	0.000734	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—CALM1—Alzheimer's disease	1.25e-05	0.000731	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—GSK3A—Alzheimer's disease	1.24e-05	0.000728	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—SST—Alzheimer's disease	1.23e-05	0.000718	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—NTRK2—Alzheimer's disease	1.23e-05	0.000718	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—GAB2—Alzheimer's disease	1.23e-05	0.000718	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—APP—Alzheimer's disease	1.22e-05	0.000716	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—CALM1—Alzheimer's disease	1.22e-05	0.000715	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—GSK3A—Alzheimer's disease	1.22e-05	0.000712	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—APP—Alzheimer's disease	1.19e-05	0.0007	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—F2—Alzheimer's disease	1.17e-05	0.000687	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—PLCB1—Alzheimer's disease	1.15e-05	0.000675	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—F2—Alzheimer's disease	1.15e-05	0.000672	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—PLCB1—Alzheimer's disease	1.13e-05	0.000661	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—NGFR—Alzheimer's disease	1.08e-05	0.00063	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—CREB1—Alzheimer's disease	1.07e-05	0.000626	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—TPI1—Alzheimer's disease	1.06e-05	0.000621	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—CHAT—Alzheimer's disease	1.06e-05	0.000621	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—NGFR—Alzheimer's disease	1.05e-05	0.000616	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—ADAM10—Alzheimer's disease	1.05e-05	0.000615	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—CCL2—Alzheimer's disease	1.05e-05	0.000613	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—CREB1—Alzheimer's disease	1.05e-05	0.000612	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—ADAM10—Alzheimer's disease	1.03e-05	0.000602	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—CCL2—Alzheimer's disease	1.02e-05	0.000599	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—MAOB—Alzheimer's disease	1.02e-05	0.000595	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—S100B—Alzheimer's disease	9.93e-06	0.000582	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—GAPDH—Alzheimer's disease	9.78e-06	0.000573	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—S100B—Alzheimer's disease	9.71e-06	0.000569	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—IGF2—Alzheimer's disease	9.46e-06	0.000554	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—A2M—Alzheimer's disease	9.44e-06	0.000553	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—IGF2—Alzheimer's disease	9.25e-06	0.000542	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—IGF1R—Alzheimer's disease	9.14e-06	0.000536	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—IGF1R—Alzheimer's disease	8.94e-06	0.000524	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—LPL—Alzheimer's disease	8.76e-06	0.000514	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—MEF2C—Alzheimer's disease	8.69e-06	0.000509	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—LPL—Alzheimer's disease	8.57e-06	0.000502	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—PRKCG—Alzheimer's disease	8.52e-06	0.000499	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—MEF2C—Alzheimer's disease	8.5e-06	0.000498	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—PRKCG—Alzheimer's disease	8.34e-06	0.000489	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—NGF—Alzheimer's disease	8.3e-06	0.000486	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—ACHE—Alzheimer's disease	8.21e-06	0.000481	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—NGF—Alzheimer's disease	8.12e-06	0.000476	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—INPP5D—Alzheimer's disease	8.12e-06	0.000476	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—CCR5—Alzheimer's disease	8.08e-06	0.000473	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—HTR2A—Alzheimer's disease	7.9e-06	0.000463	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—CCR5—Alzheimer's disease	7.9e-06	0.000463	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—HTR2A—Alzheimer's disease	7.73e-06	0.000453	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—ENO1—Alzheimer's disease	7.7e-06	0.000451	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—PTGS1—Alzheimer's disease	7.7e-06	0.000451	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—CALM1—Alzheimer's disease	7.37e-06	0.000432	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—APOE—Alzheimer's disease	7.35e-06	0.000431	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—LEP—Alzheimer's disease	7.35e-06	0.000431	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—CAV1—Alzheimer's disease	7.28e-06	0.000427	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—CALM1—Alzheimer's disease	7.21e-06	0.000423	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—LEP—Alzheimer's disease	7.19e-06	0.000421	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—APOE—Alzheimer's disease	7.19e-06	0.000421	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—BCHE—Alzheimer's disease	7.15e-06	0.000419	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—CAV1—Alzheimer's disease	7.12e-06	0.000417	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—ESR1—Alzheimer's disease	7.01e-06	0.000411	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—F2—Alzheimer's disease	6.93e-06	0.000406	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—ESR1—Alzheimer's disease	6.86e-06	0.000402	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—NOTCH1—Alzheimer's disease	6.78e-06	0.000397	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—F2—Alzheimer's disease	6.78e-06	0.000397	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—PLCB1—Alzheimer's disease	6.75e-06	0.000396	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—NOTCH1—Alzheimer's disease	6.63e-06	0.000389	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—ABCA1—Alzheimer's disease	6.54e-06	0.000383	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—GSK3B—Alzheimer's disease	6.36e-06	0.000373	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—CREB1—Alzheimer's disease	6.31e-06	0.00037	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—INS—Alzheimer's disease	6.28e-06	0.000368	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—GSK3B—Alzheimer's disease	6.22e-06	0.000365	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—CCL2—Alzheimer's disease	6.18e-06	0.000362	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—CREB1—Alzheimer's disease	6.17e-06	0.000362	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—INS—Alzheimer's disease	6.14e-06	0.00036	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—IGF1—Alzheimer's disease	6.07e-06	0.000356	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—CCL2—Alzheimer's disease	6.04e-06	0.000354	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—IGF1—Alzheimer's disease	5.94e-06	0.000348	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—PPARGC1A—Alzheimer's disease	5.64e-06	0.000331	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—HMOX1—Alzheimer's disease	5.61e-06	0.000329	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—NOS3—Alzheimer's disease	5.5e-06	0.000323	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—NOS3—Alzheimer's disease	5.38e-06	0.000316	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—LPL—Alzheimer's disease	5.13e-06	0.000301	CbGpPWpGaD
Carteolol—ADRB1—GPCR downstream signaling—AKT1—Alzheimer's disease	4.72e-06	0.000276	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—CASP3—Alzheimer's disease	4.67e-06	0.000274	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—IL6—Alzheimer's disease	4.64e-06	0.000272	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—MTHFR—Alzheimer's disease	4.62e-06	0.000271	CbGpPWpGaD
Carteolol—ADRB2—GPCR downstream signaling—AKT1—Alzheimer's disease	4.61e-06	0.00027	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—CASP3—Alzheimer's disease	4.57e-06	0.000268	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—IL6—Alzheimer's disease	4.54e-06	0.000266	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—CALM1—Alzheimer's disease	4.32e-06	0.000253	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—APOE—Alzheimer's disease	4.3e-06	0.000252	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—MAPK8—Alzheimer's disease	4.29e-06	0.000252	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—AKT1—Alzheimer's disease	4.28e-06	0.000251	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—CAV1—Alzheimer's disease	4.26e-06	0.00025	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—MAPK8—Alzheimer's disease	4.2e-06	0.000246	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—AKT1—Alzheimer's disease	4.19e-06	0.000246	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—VEGFA—Alzheimer's disease	3.97e-06	0.000232	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—VEGFA—Alzheimer's disease	3.88e-06	0.000227	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—PPARG—Alzheimer's disease	3.75e-06	0.00022	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—INS—Alzheimer's disease	3.68e-06	0.000215	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—TGFB1—Alzheimer's disease	3.64e-06	0.000213	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—TGFB1—Alzheimer's disease	3.56e-06	0.000209	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—NOS3—Alzheimer's disease	3.22e-06	0.000189	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—TP53—Alzheimer's disease	3e-06	0.000176	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—PTGS2—Alzheimer's disease	2.95e-06	0.000173	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—TP53—Alzheimer's disease	2.93e-06	0.000172	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—IL6—Alzheimer's disease	2.74e-06	0.000161	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—IL6—Alzheimer's disease	2.68e-06	0.000157	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—AKT1—Alzheimer's disease	2.53e-06	0.000148	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—AKT1—Alzheimer's disease	2.47e-06	0.000145	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—AKT1—Alzheimer's disease	1.48e-06	8.69e-05	CbGpPWpGaD
